Are National Cancer Control Indicators for patient experiences being met in regional and remote Australia? A cross-sectional study of cancer survivors who travelled for treatment.
adult oncology
health services administration & management
organisation of health services
quality in health care
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
22 02 2021
22 02 2021
Historique:
entrez:
23
2
2021
pubmed:
24
2
2021
medline:
15
5
2021
Statut:
epublish
Résumé
To examine the health services experience of patients with cancer from regional and remote Australia using the Australian National Cancer Control Indicators (NCCI) guidelines as an assessment framework. Cross-sectional. Queensland non-for-profit cancer accommodation lodges. Participants were patients with cancer who travelled for treatment from rural and remote Queensland to major urban centres (n=518; age mean=64.6, SD=11.18). Assessments included NCCI patient indicators, quality of life (QoL), psychological distress and unmet supportive care needs. The frequency at which NCCI indicators were met ranged from 37.5% for receiving an assessment and care plan to 97.3% for understanding explanations about diagnosis. Geographical considerations did not impact patient experience, whereas middle school educated participants were more likely than those with senior-level education or higher to receive an assessment and care plan (OR=1.90, 95% CI 1.23 to 2.91) and to report having their views on treatment taken into account (OR=2.22, 95% CI 1.49 to 3.33). Patients with breast or prostate cancer reported better communication and patient involvement and information and services provision ( The patient care experience varies across the NCCI indicators by sociodemographic and clinical factors that likely reflect healthcare system biases. Perceptions about communication and involvement appear most critical for optimal outcomes and should be a priority action area for cancer control.
Identifiants
pubmed: 33619187
pii: bmjopen-2020-042507
doi: 10.1136/bmjopen-2020-042507
pmc: PMC7903096
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e042507Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Health Psychol. 2014 Nov;33(11):1382-90
pubmed: 25089344
Psychooncology. 2010 Jun;19(6):637-45
pubmed: 19582800
Eur J Oncol Nurs. 2004 Dec;8(4):306-14
pubmed: 15550360
Cancer Nurs. 2018 Sep/Oct;41(5):E11-E22
pubmed: 28753191
Aust J Rural Health. 2018 Jun;26(3):157-164
pubmed: 29913059
Soc Sci Med. 1995 Apr;40(8):1021-8
pubmed: 7597456
Acta Oncol. 2015 May;54(5):805-12
pubmed: 25813474
J Clin Nurs. 2020 Jan;29(1-2):265-273
pubmed: 31713906
BMC Cancer. 2017 Feb 2;17(1):95
pubmed: 28152983
Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:5267-9
pubmed: 21096054
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Psychooncology. 2020 Mar;29(3):557-563
pubmed: 31944447
J Psychosoc Oncol. 2006;24(2):85-101
pubmed: 17046808
Cancer. 2013 Mar 1;119(5):1050-7
pubmed: 23096263
Front Oncol. 2019 Apr 08;9:238
pubmed: 31024842
Support Care Cancer. 2012 Jan;20(1):1-22
pubmed: 21956760
J Eval Clin Pract. 2009 Aug;15(4):602-6
pubmed: 19522727
Surgery. 2018 Mar;163(3):553-559
pubmed: 29179915
J Cancer Res Clin Oncol. 2016 May;142(5):1079-89
pubmed: 26762849
Am Soc Clin Oncol Educ Book. 2019 Jan;39:625-639
pubmed: 31099658
Psychooncology. 2008 Apr;17(4):392-400
pubmed: 17680554
Patient Educ Couns. 2010 May;79(2):218-24
pubmed: 20005066
CA Cancer J Clin. 2014 Nov-Dec;64(6):377-88
pubmed: 25200391